Molecular Characterization Informs Prognosis in Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group.

J Clin Oncol · 2025 · PMC12614438 · PMID 41183255

Europe PMC DOI

hedged sentence

0.0960

closest p · 1.9× alpha

0.0960

boldest claim

The sentences

did not reach statistical significanceP = .096so close (0.05 < p ≤ 0.1)

Those with TP53 mutation and/or recurrent CNAs without an STAG2 mutation had a directionally increased risk of RFS event relative to those with no molecular lesion (79.6%; 95% CI, 72.0% to 88.1%), but this did not reach statistical significance (BH-corrected log-rank P = .096; Fig 3 A).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.